Project Details
| Short title | HRS-3802-101 |
|---|---|
| Status | Active |
| Effective start/end date | 4/11/25 → 11/08/26 |
CTU: HRS-3802-101 A single-arm, open-label, multi-center phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics of HRS-3802 monotherapy in patients with malignant solid tumours
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Delahunt Smoleniec, Jacqui (Primary Chief Investigator)
- Lawrie, Angus (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
Project: Research